Sunday, October 20, 2019

Sunday, October 20, 2019

VivaQuant


Recent News About VivaQuant View More

VIVAQUANT: Receives FDA 510(k) Clearance for its RX-1 Rhythm ExpressTM Arrhythmia Device

VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device.


FDA Reporter